Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 14, Issue 4, Pages 419-422Publisher
EXPERT REVIEWS
DOI: 10.1586/14737159.2014.905203
Keywords
plasma; hypomethylation; copy number aberrations; cancer detection; next generation sequencing
Categories
Funding
- FCT - Fundacao para a Ciencia e a Tecnologia - Ministry of Science and Education [EXPL/BIM-ONC/0556/2012]
- Research Center of Portuguese Oncology Institute - Porto [CI-IPOP 4-2012]
- Fundação para a Ciência e a Tecnologia [EXPL/BIM-ONC/0556/2012] Funding Source: FCT
Ask authors/readers for more resources
Evaluation of: Chan KC, Jiang P, Chan CW et al. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc. Natl Acad. Sci. U.S.A. 110(47), 18761-18768 (2013). Early cancer detection strategies are required to identify patients at initial stages, when curative-intended treatment is more effective. Assessment of genome-wide hypomethylation might allow for early cancer detection in bodily fluids, but requires high throughput technologies, such as next generation sequencing. In the study under evaluation, performance of a hypomethylation and copy number aberration (CNA) assay for detection of hepatocellular carcinoma (HCC), based on massive parallel bisulfite sequencing of plasma DNA was assessed. Sensitive (92/69%) and specific (88/94%) HCC detection (using 'OR'/'AND' algorithms) was achieved using a mean sequencing depth of 93 million reads in one lane. Using the 'AND' or the 'OR' algorithms, other cancer types were detected with 60% sensitivity and 94% specificity, or 85% sensitivity and 88% specificity, respectively. Lowering sequencing depth to 10 million reads (decreasing analysis time and cost) did not alter hypomethylation performance but impaired that of CNA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available